Cellular Senescence and Their Role in Liver Metabolism in Health and Disease: Overview and Future Directions by Schade, Matthew et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 4
Cellular Senescence and Their Role in Liver Metabolism
in Health and Disease: Overview and Future Directions
Matthew Schade, Jacqueline A Sanabria,
Milad Modarresi, Bryan Gillon, Zach Hunter,
Jacqueline Fannin, Amrita Mallick,
Henri Brunengraber and Juan Sanabria
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.71659
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited. 
Matthew Schade, Jacqueline A Sanabria, Milad Modarresi, 
Bryan Gillon, Zach Hunter, Jacqueline Fannin, 
Amrita Mallick, Henri Brunengraber and Juan Sanabria
Additional information is available at the end of the chapter
Abstract
Chronic liver disease has globally risen mainly due to a prevalent hepatitis C virus (HCV) 
infection rate and an epidemic of obesity. It is estimated by the year 2030, 2.2 billion people 
around the world will be overweight and 1.1 billion people will be obese. Diabetes and obe-
sity are the main risk factors for the development of the metabolic syndrome and in the liver 
of non-alcoholic fatty liver disease (NAFLD) which could progress to non-alcoholic fatty ste-
atohepatitis (NASH) related cirrhosis and liver malignancy. At present there is not effective 
therapy for NASH besides loss of weight and exercise. Furthermore, optimal management 
of HCC with curative intent includes resection or liver transplantation. Nevertheless, these 
therapies are limited because the degree of liver dysfunction or the medical conditions at the 
time of diagnosis and the scarcity of available liver grafts. The role of cellular lipid manage-
ment and metabolism in human health and disease is taking a center stage. The present over-
view articulates the current pathophysiology of fatty liver disease under the aging processes, 
potential biological markers of liver disease diagnosis and progression and future therapies.
Keywords: review, senescence, cell aging, mitochondrial function, cancer, obesity, 
NASH, ROS, lipids, metabolism
1. Introduction
1.1. Global burden of chronic liver disease
Chronic liver disease has globally risen due to mainly a prevalent hepatitis C virus (HCV) 
infection rate and an epidemic of obesity [1–7]. During the last 2 decades, global viral hepatitis 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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has increased by 163% (from 0.89 million to 1.45 million) and in 2013, viral hepatitis infections 
became the 7th leading cause of death [7]. While HBV infection is decreasing in most endemic 
areas due to successful vaccination policies, HCV infection lacks the benefits of a vaccine [7]. 
Even though HVC antiviral therapies recently introduced in clinical practice are highly suc-
cessful, its implementation is limited due to access and/or financial constraints. Morphological 
studies in HCV showed hepatocyte lipid accumulation similar to the one that occurs in obesity.
Our group has estimated that 2.2 billion people will be overweight and 1.1 billion people will be 
obese globally by 2030 [8, 9]. In addition, 36.1% of adult men and 32.4% of adult women were 
diagnosed with the metabolic syndrome in 2010 [10]. Obesity represents the core component of 
the metabolic syndrome, a cluster of metabolic disarrangements including dyslipidemias, insulin 
resistance status, hypertension, diabetes and organ metabolic disturbances such as non-alcoholic 
fatty liver disease (NAFLD) and its inflammatory component non-alcoholic fatty steatohepatitis 
(NASH), nephropathy, cardiomyopathy and muscle dysfunction [10]. Hepatocellular carcinoma 
(HCC) has been reported more often in non-cirrhotic livers in the background of NASH and 
its risks factors include male gender, older age, cigarette smoking, obesity and insulin-resistant 
states [3, 4, 11]. Overweight and obesity are associated with an overall increase in liver primary 
cancers of 17% and 89%, respectively [2, 11, 12] and males with a BMI > 35 had a 3.5–4 increase 
risk of liver malignancy [12] (Figure 1). Optimal management of HCC with curative intent 
includes resection or liver transplantation. Nevertheless, these therapies are limited because the 
Figure 1. Main causes of end stage liver disease (ESLD) and hepatocellular carcinoma (HCC). Hepatitis C virus infection (HCV) and 
obesity are the main cause of the global and Western increase in ESLD and HCC. In USA 1 out of 3 adults is overweight and 
approximately 5 M people is HCV seropositive. While prevention relays in stopping virus transmission and implementing 
programs of healthy caloric intake and exercise programs, treatments of established ESLD and its malignant consequence 
are similar. Nevertheless, the most effective surgical treatment, liver transplantation is limited due to scarcity of donors 
and loco-regional therapies have limited survival effect due to malignant recurrence or progression of liver dysfunction.
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degree of liver dysfunction or additional medical conditions at the time of diagnosis and the 
scarcity of available liver grafts. The role of cellular lipid management and metabolism in human 
health and disease is taking a center stage [13]. Higher fat intake, lower physical activity and a 
progressively aging population are among the behavioral and social factors of this phenomenon 
that add to the genetic load [1]. An overview of the role of cell aging and senescence in liver meta-
bolic responses to high caloric intake will be performed in the pages to follow.
1.2. Regeneration, necrosis, apoptosis and senescent: a constant changing balance
The liver is a unique organ with an innate ability to regenerate through mass compensation 
to satisfy portal flow and metabolic demands [14]. After injury and cell necrosis, immune 
recall of resting cells occurs and activation of oval-precursor cells in conjunction with plate-
lets migration switch to a cell division renewal cycle [15, 16]. Mitosis is more prominent at 
the peri-portal stem cell niche site (zone 1) assuring clonal expansion until reaching zone 3 
(peri-central vein) [15, 16]. In health, liver mass homeostasis is closely regulated through a 
delicate balance among regeneration, apoptosis (programmed cell termination), and senes-
cence. During states of acute liver injury, the pendulum moves towards a regenerative and 
repair phase, however, during chronic states of liver injury collagen synthesis and deposition 
persists leading to organ fibrosis. In addition, natural processes of organ aging play a main 
role in organ response to both acute and chronic injuries. Primary cell life span is determined 
by a limited number of cell duplications, the so called Hayflick limit [17]. After such limited 
divisions, cells enter a state of cell replicative senescence which is believed to be triggered by 
shortening of telomere ends. Replicative cellular senescence is a stable form of cell arrest char-
acterized by a lack of cell proliferation activity and apoptosis resistance mediated through 
a lack of mitogen response even though the cells remain metabolically active. On the other 
hand, cells can be induced to a senescence status by a variety of cellular stressors such as DNA 
damage, UV light, radiation, oncogene activation, increased H
2
O
2
 production and heat stress 
[17, 18]. Senescent cells undergo morphological changes as they acquire an enlarged and flat-
tened morphology, in addition to an increase expression of the senescence associated markers 
ß-galactosidase (SA-ß-GAL), an accumulation of the senescence associated heterochromatic 
foci (SAHF) and DNA damage foci, and the expression of the senescence associated secretary 
phenotype (SASP) [18]. Senescent status is achieved and maintained by active signaling of 
p53, a tumor suppressor gene that exercises its effects through activation of p21, a potent cell 
cycle inhibitor, and the p16-retinoblastoma protein [18]. Cells induced into an irreversible 
cell cycle arrest at the G1 phase will undergo metabolic disturbances with an increase reac-
tive oxygen species (ROS) production, decrease adenosine triphosphate (ATP) synthesis and 
accumulation of lipofuscin [17].
Changes in the content of daily oral intake can influence life span and thus cell aging. The 
cell death-inducing DNA fragmentation factor α-subunit-like effector A (Cidea), is a tran-
scriptional coactivator implicated in lipid accumulation, cell stress and cell aging. Authors 
showed in rodents, that a high lipid diet up-regulated Cidea with hepatic lipid accumula-
tion, cell stress, mitochondrial dysfunction and genetic upregulation of aging [19]. Other 
studies, in support of this findings have shown a life span reduction up to 30% in genetically 
obese mice (ob/ob) and this reduction was reversed by a caloric restricted diet [19]. Lipid 
enriched diets are associated in humans with DM type 2, HTN and cardiovascular events all 
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of which limit life span. Caloric restriction without malnutrition can extend life span while 
caloric excess has the opposite effect [20]. Thus, the choice of oral intake has a profound 
impact on life span.
The free radical intermediates hypothesis of cell aging still remains the most reasonable in the 
induction and maintenance of the senescent status [17, 21]. ROS, reactive nitrogen sp., and 
lipid peroxide are important regulators of cell signaling that provides reliable maintenance of 
Figure 2. (A) Morphological changes observed in the mice model of high fat diet (HFD) plus fructose (Western Diet) in the 
microbiota, fat content tissue and liver. Liver cells accumulate FA in form of TG from the spill-over of lipid excess in the fat 
compartment and after saturated the normal processes of liver lipid metabolism. (B) Local liver inflammatory response from 
lipid excess. Lipotoxicity an addition to increase LPS activates SEC, HSC and Kupffer cells inducing more parenchymal 
cells into senescence and apoptosis which changes the local mielue into an inflammatory microenvironment. Continuous 
HFD decreased further mitochondrial function with lower ATP production and increase collagen deposition leading 
to progressive liver fibrosis, liver dysfunction. The state of progressive liver fibrosis due to a local and systemic 
inflammatory state results in an increasing insulin resistance status with the full metabolic syndrome phenotype. Its 
progression results in decompensated ESLD and the development of malignancy.
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cellular components, support redox-state and regulate the function of highly metabolic active 
cells as in hepatocyte and immune cells [20, 21]. ROS in excess from over-oxidation of lipids, 
proteins, nucleic acids and other macromolecules is associated with a misalignment of their 
functional activity, reactions that if they last through the cell cycle can lead to permanent cell 
dysfunction and/or accelerated aging cell process. Thus, an excess of food intake in form of 
continuous lipid charge will test the oxi-redox systems that keeps the fragile mitochondrial 
equilibrium in balance. Continuous metabolic stress changes the equilibrium towards lower 
levels of antioxidants (glutathione sp.) with further increase of ROS that in turn accelerates 
processes of apoptosis and senescence. Former processes further lead to arrest of regenera-
tion and activation of hepatic stellate cells (HSC) and therefore fibrogenesis (Figure 2A).
The hormonal mielau modulates cellular response to caloric intake. Insulin and somatotro-
pin signaling are critical not only in the control of cell aging and longevity under conditions 
of abundant food supply but also in mediating the effects of caloric restriction on life span. 
In a rodent model of thyroxine induced aging, thermogenesis was directly correlated with 
increased mitochondrial function, increased ROS production, decreased concentration of glu-
tathione reduced, downregulation in the activity of antioxidants enzymes and increased senes-
cent marker expression in the liver as well as in other organs [21]. Estrogen influences lipid 
metabolism through nuclear receptors which enhances apoptosis of mutated cells, improves 
mitochondrial function, and decreases the metabolic syndrome phenotype [10, 22]. Actions 
that may explain, at least in part the constant disparity of overall life expectancy by gender.
Lifestyle changes such as exercise and caffeine supplementation have shown to increase the 
ratio of reduced/oxidized glutathione in liver and muscle tissue in the rodent model [23]. 
Although liver enzymes were identical in experimental and controls groups, plasma levels of 
cytokines associated with inflammation (IL-1ß, IL-6, TNF-α and INF-α) and cell aging were 
found to be significantly decreased in the experimental group when compared to controls [23]. 
It was noted that although exercise increased the production of ROS, exercise also evoked a 
beneficial increase in levels of cell antioxidants, and lowered levels of oxidative damage when 
cells were exposed to a second injury, i.e. lipid charge. Thus, the concept of exercise inducing 
gene expression of antioxidant enzymes that may protect the cell from other insults was called 
‘hormesis’ [23]. Although caffeine, a member of the methyl-xanthine family increased the 
ratio of reduced-oxidized glutathione, no other markers of cell stress were modified. Perhaps, 
caffeine potentiates further the beneficial effects of exercise.
2. Liver metabolism in health and disease
The reduced tri-peptide glutathione (GSH) is the major antioxidant in the body responsible 
for maintaining the intracellular redox balance. 90% of the GSH in plasma derives from the 
liver [24] and aging is associated with a progressive decline in the levels of GSH in humans 
and rodents [25]. Senescent liver cells in culture showed elevated ROS leading to a state of 
chronic oxidative stress. In addition, age associated decline in GSH has been linked to an acti-
vation of neural sphingolipid hydrolase enzyme (NSMase) and the accumulation of bioactive 
ceramide, a precursor of inflammation [25]. The availability of L-cysteine is the rate-limiting 
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factor of GSH synthesis and oral supplementation of cysteine alleviates GSH deficiencies in 
humans and rodents [25]. GSH deficiency can be alleviated by the oral intake of cysteine and 
its restoration rates appears to be age and sex dependent. Older animal models are associated 
with increased cellular stress and an enhanced subcellular injury after heat stress associated 
with an increased iron intracellular deposition [26]. These cause damages to mitochondria 
and lysosomes. Although a more precise mechanism of organelle damage was not enunci-
ated, iron deposition mediated a decrease in Transferrin-receptor-1 which upregulates the 
iron storage protein ferritin after heat stress. Nevertheless, the synthesis of the iron exporter 
protein ferroportin was delayed [26]. Effect that may explain at least in part, organelle dam-
age in the aging cell that occurs after natural oxidants depletion (Figure 2B).
A diet enriched in calories and lipids increases free fatty acids (FA) in plasma obligating cells 
to protect themselves from lipotoxicity or death by either oxidizing FA’s or sequestering them 
as triacylglycerol (TAG) within lipid droplets (LD) [13]. PGC-1, an exercise-induced transcrip-
tional coactivator may play an important role in coordinating intra-muscular LD-signaling with 
mitochondrial remodeling. TAG within lipid droplets are the major form of energy storage in 
the body (muscle, liver, fat tissue) and a reservoir of membrane lipid component. TAG synthe-
sis is initiated by glycerol-3-phosphatase acetyltransferases (GPAT) at the mitochondrial and 
sarcoplasmic reticulum membranes and it is completed at the sarcoplasmic reticulum by the sn-
1-acyl-glycerol-3-phosphatase acyltransferase (AGPAT), phosphatidic acid phosphatase (PAP) 
and sn-1,2-diacylglycerol acyltransferase (DGAT) [13]. Synthetized LD-TAG are localized pref-
erentially in proximity to mitochondrial membranes named “contact zones”. Once TAG’s are 
released, they are mainly used in the mitochondria for ATP synthesis via oxidative phosphory-
lation from the ß-oxidation path. The “athlete paradox” states that the accumulation of TAG 
in the trained and insulin sensitive cells is in greater proportion than the TAG accumulation in 
cells from diabetic subjects with insulin resistance. This observation supports the hypothesis 
of mitochondrial dysfunction as a factor of TAG accumulation from a sustained lipid charge.
The protein family of perilipins (Plin) is associated with LD’s and their scaffolding may 
affect the interaction between TAG and the mitochondria [13]. The Plin family consists of 
Plin1 to 5; the most common PAT (perilipin/ADRP/TIP47) interacts with LD in different 
proportions. In the liver, down-regulation of Plin2 promotes a reduction of hepatic steato-
sis and increases insulin sensitivity, albeit a reduction in both Plin2 and Plin3 is associated 
with insulin resistance [13]. In the heart, a Plin5 deficiency causes increased lipid oxidation, 
increased ROS production and decreased cardiac function. In heart and skeletal muscle TAG 
and FA are the main metabolic source of energy through the ß-oxidation pathway, suggest-
ing a very tightly regulated process from cell storage to mitochondrial metabolic use. While 
TAG may come from LD, FA’s are mainly transported in plasma as albumin-bound or as part 
of the very low density lipid-protein (VLDL) complex. Different transmembrane transporter 
systems are involved in their translocation to the inner cell compartment where the long 
chain fatty acid (LCFA) forms thioesters with coenzyme A (CoA). LCFA-CoA can form TAG 
for storage as LD, or can enter the outer mitochondrial membrane where CPT1 catalyzes 
the reaction of LCFA-CoA to LC-acylcarnitine. The former compound can actively cross the 
inner mitochondrial membrane with the exchange of carnitine for acylcarnitine. CACT is 
highly expressed in tissues with predominant ß-oxidation metabolism.
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2.1. In Health
The metabolism of FA in the mitochondrial matrix is sequentially catalyzed through a ß-oxi-
dation process by four enzyme families: acyl-CoA dehydrogenase, enoyl-CoA hydratase, 
3-hydroxyacyl-CoA dehydrogenase and 3-ketoacyl-CoA thiolase. While acyl-carnitine is con-
verted back to acyl-CoA to enter the TCA cycle, dehydrogenases activity shows different affinity 
for short, medium, long and very long FA’s [13]. Every cycle of ß-oxidation renders acyl-CoA 
and shortens the FA chain by 2 carbons providing the equivalents of electron donors NADH 
and FADH
2
 which is the driving force for the synthesis of ATP. Although the ß-oxidation path-
way is an effective way of ATP production, an overload of FA may play the role of un-coupler 
that exercises an inhibitory effect on the respiratory chain through a proton-phoric effect on the 
inner mitochondrial membrane. This effect results from the implicit effect of FA on mitochon-
drial membrane porosity by opening of the permeability transition pores, which results in the 
subsequent loss of electrical gradient and arrest of the respiratory chain [13]. The above concept 
favors the hypotheses of mitochondrial dysfunction from FA overload as the primary step of the 
insulin resistance state in obese patients. Other authors have found no mitochondrial respiratory 
changes in the steatotic liver but in mitochondria from skeletal muscle from a rodent model of 
high fat diet induced obesity [27]. Authors have proposed mitochondrial changes are due to an 
adaptation of the mitochondria to the high lipid charge rather than a defect per se in its function. 
No explanation was provided by the authors regarding the increase in ROS and inflammatory 
changes observed. Others suggested a protected effect from caloric lipid surplus against the 
development of metabolic dysfunction, as long as cells maintained functional adipocyte storage 
with low levels of tissue inflammation [28]. Once adipose accumulation saturates cell capacity, 
fatty excess spills over into other tissues leading to LD accumulation with subsequent lipid oxi-
dation and an inflammatory response which precedes the metabolic syndrome manifestations 
[28]. The Delete in Breast Cancer-1 (DBC-1) protein is an important regulator of fat accumulation 
and storage in fat tissue which exercises its action by inhibition of SIRT1. In the DBC-/KO mice 
exposed to HFD, it was observed high plasma levels of FA with no liver steatosis, lower expres-
sion of senescence cells and increased storage of FA in the adipocytes with no development of 
insulin resistance [28]. Thus, DBC-1 protected liver and adipocytes from senescence by preserva-
tion of the fat compartment function with liver sparing and insulin sensitivity. Interestingly, a 
comparison has been made between this rodent model and the so called “healthy obese subjects” 
where there is fat accumulation but no signs of metabolic syndrome or systemic inflammation.
2.1.1. Metabolism and inflammation
Obesity depresses the anti-inflammatory effects of the heat shock proteins (HSP70) pathway, 
an inhibition that may contribute to the progression from NAFLD to NASH [29]. Excess of 
lipids and fuels trigger a low grade inflammatory response in both fat and liver tissues that 
correlates with the impaired insulin responsiveness. TBARS, a simple but fair estimate of 
lipoperoxidation/malondialdehyde (systemic oxidative stress) produced throughout the 
body was shown to be elevated in plasma from NASH patients when compared to normal 
subjects and its levels were correlated with insulin-resistance status [29]. The former response 
involved activation of the c-Jun NH2-terminal kinases (JNK’s), endoplasmic reticulum (ER) 
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stress, unfolded proteins response (UPR), and the ceramide pathway by blocking nuclear fac-
tor κB (NF-κB) expression at different levels [29]. In liver tissue, HSP70 downregulates TNF-α 
and inducible nitric oxide synthase (NOS2), genes that increase the inflammatory response 
in rodents. In addition, HSP70 in humans induces apoptosis and increases the concentration 
of cyclopentenone prostaglandins, a potent local inhibitor of inflammation. In human liver 
and fat tissues, the suppression of HSP70 was strongly correlated with the upregulation of 
JNK1 and JNK2 [29]. The authors hypothesized that the senescence-like state in fat cells have 
evolved in obese individuals as an adaptation to the metabolic overutilization of fat cells, sup-
porting the observation that hepatocyte senescence predicts NAFLD progression to NASH 
and to cirrhosis. Patients with different grades of ESLD from NASH or HCV had signifi-
cantly decreased levels of glutathione reduced and increased levels of glutathione oxidized in 
plasma when compared to healthy controls [30]. Therefore, a continuous increase in the cell 
oxidative stress consumes the antioxidant protective mechanisms and increases the spillage 
of oxidative molecules. Increased oxidative compounds accumulation may induce a progres-
sive larger number of liver cells into senescence which in turn will enlarge the SASP compo-
nent worsening the inflammatory environment with further increase of stressors into the liver 
mieleu by triggering an activation of local and systemic immune-regulators (Figure 3).
In old mice, hyperglycemia increased chromatin remodeling and polyploidy levels; changes 
observed as well in non-obese diabetic mice [31]. Genes involved in glycemic control and 
metabolism are also involved in inflammation such as Ppargc1a (PGC-1α). It acts on the histone 
deacetylase SIRT1 as a metabolic sensor in hepatocytes and increases gene activation involved 
in the gluconeogenesis pathway [31]. Furthermore, PGC-1α also plays a role in lipid metabo-
lism [31]. Through the thyroid receptor pathway, it induces the expression of Srb1 (Scavenger 
receptor B member 1), enhances the uptake of cholesterol esters from high density lipoproteins 
(HDL) in the liver and inhibits the expression of Srebp-1 (sterol regulatory element-binding 
transcription factor-1) down-regulating fatty acid synthesis [31]. As SASP builds up due to 
an increasing number of cells entering senescence, an increasing insulin resistance state starts 
to develop with its manifestation, hyperglycemia which further favors replicative cell arrest.
The fat compartment has emerged not only as an energy reservoir but as an endocrine organ 
capable of modulating metabolic states where the adiponectin/leptin ratio determines an anti 
or pro-inflammatory response. Leptin is a 167-aminoacid hormone expressed predominantly 
in adipocytes. Its signaling is an important determinant of food intake, adiposity and energy 
expenditure [32]. In the ob/ob mouse, a homozygous mutation in the gene that encodes leptin 
is associated with increased appetite, obesity and an insulin-resistant state. When leptin was 
provided to the ob/ob animal, there was a dramatic improvement in glucose homeostasis 
and energy metabolism. Although leptin related glucose homeostasis is largely conserved 
in rodents and humans, most subjects with insulin-resistant diabetes have a hyperleptin-
emic state with a central resistance to leptin [32]. Adiponectin is a protein hormone of 244 
amino acids synthesized as a monomer of 28–30 kDa and assembled in various molecular 
weights: low, medium and high molecular weight (LMW, MMW and HMW) oligomers [33, 
34]. HMW oligomers are the major relevant forms in terms of physiological activities of adi-
ponectin while, low amounts of HMW oligomers represent an independent risk factor for 
several metabolic pathologies such as obesity-related diseases. Adiponectin plays a pivotal 
role in energy metabolism being an insulin-sensitizing hormone and it is involved in a wide 
variety of physiological cellular processes including inflammation, immunity and vascular 
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 physiology. Adiponectin acts through three major physiologically different and distinctly 
expressed receptors: AdipoR1, AdipoR2 and T-cadherin. Adipo receptors mediate pleiotropic 
adiponectin actions through signaling mechanisms involving AMPK, ERK1/2, AKT and P38. 
In addition, Polymerase I and transcription release factor (PTRF) regulates adipocyte differen-
tiation, perhaps fat cell senescence and thus may determine fat compartment expandability, 
condition that under continuous HFD exposure increase the spill-over of FFA to the liver in 
combination to a pro-inflammatory adipokine repertoire [35].
2.1.2. Signaling of energy expenditure and metabolism
Rapamycin has an effect in cell life span with significant changes in the liver transcriptome, 
effects that are more pronounced when animals are exposed to caloric restriction [36, 37]. In 
a rodent model, rapamycin prevented senescent changes with significant differences by gen-
der but with some common genetic pathways, mainly in the preservation of mitochondrial 
function. Those pathways included protein ubiquitination, NRF2-mediated oxidative stress 
response and glucocorticoid and OGF-1 signaling [36, 37]. Cell culture studies, indicated 
that treatment with rapamycin decreased mitochondrial membrane potential, decreased O
2
  
Figure 3. Local and systemic responses that occur in the progression of NAFLD to NASH and ESLD associated HCC and their 
metabolomic print. The liver local progression from NAFLD to NASH is associated with a local inflammatory response 
that eventually involves several other organs evolving into a systemic reaction. The systemic inflammatory response is 
associated with the development of an insulin resistance status and the metabolic syndrome phenotype: HTN, central 
obesity, DMType II and NASH. The continuous liver lipotoxicity decreases mitochondria function and decreases 
ATP production as well as enhances the secretion of lipid intermediates which are toxic to CD4 T lymphocytes. All 
together enhances a regenerative stimulus of senescence cells with mitochondrial dysfunction generating at some point 
a metabolic swap of ATP production to the cytosol, which may be associated with a mitochondrial generated apoptotic 
switch and in an environment of progressive fibrosis and therefore low oxygen and nutrients delivery favoring the 
survival of the already highly mutated cells which in turn have escaped physiological cell cycle control and immuno-
recognition assuring cell clone growth. Metabolic disturbances precede variations in cell cycle and genetic expression 
creating metabolic signatures of liver status in health and disease.
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consumption, and increased ATP production [36, 37]. Other effects from transcriptome path-
ways include a decrease in proteasome activity in parallel with an increase in cell autophagy, 
suggesting protein quality improvement processes and increased resistance to oxidative cell 
stress effects associated with reduced cell aging.
A highly conserved signaling pathway in all eukaryotic cells is the Target of Rapamycin (TOR), 
which plays a central role as regulator of cell growth and metabolism. The mammalian TOR 
complex (mTOR) encompasses two structurally and distinct proteins. While the mTORC1 is 
associated with anabolic processes such as protein synthesis, lipid synthesis, nutrient uptake 
and inhibition of catabolic processes including autophagy, mTORC2 is an insensitive to rapamy-
cin regulation protein. mTOR2 becomes activated by a family of kinases like the serum/gluco-
corticoid kinase (SGK) and protein kinase C (PKC). mTORC1 is upregulated by growth factors, 
cellular energy status and is inhibited by the macrolide rapamycin [36–38]. Protein synthesis is 
one of the most energy demanding cell functions; a favorable redox status activates mTORC1 
which in turn exercises its actions down-stream through the ribosomal protein 6 kinase (S6K) 
and the eukaryotic translation initiation factor 4E binding protein (4R-BP) [36–38]. Due to the 
high demand of ATP, mitochondrial function regulation is of paramount importance on mTOR 
signaling pathways. Moreover, mitochondrial dysregulation and continuous mTOR activation 
may play a metabolic central role in the transformation and survival of cancer cells. Mutated 
cells with malignant potential may shift their bioenergetic state from ATP mitochondrial pro-
duction to cytosol ATP production through the tricarboxylic acid (TCA) cycle. A connection 
between mTORC2 and mitochondrial function and cancer appears to be dependent through 
the HK2 pathway [38]. Nevertheless, recently mTORC2 has been linked to cytoskeleton regu-
lation through the actin remodeling pathway, which has been suggested to have an effect on 
insulin sensitivity/resistance balance [36, 37]. Whole energy expenditure was affected by the 
mTORC1 signaling pathway, as demonstrated in the tissue specific knockout mice where a 
down-regulation of signaling pathways on adipose tissue also impacts on thermogenesis and 
systemic sensitivity to insulin [38]. In addition, mTORC2 signaling pathway, in the same animal 
model was a crucial regulator of liver and pancreas metabolism affecting animal growth and 
insulin homeostasis. mTORC 1 and 2 signaling in the liver affects systemic glucose and insulin 
homeostasis mainly due to their effects on Akt and hepatic glucose uptake. Interestingly, liver 
tumors in the tissue specific raptor knockout mice, showed a shift from glucose to glutamine as 
the main fuel source, making tumor cells glutamine addictive with high expression of mTORC1 
and FGF-21. Rapamycin treatment may be beneficial as it may inhibit growth on glutamine 
addictive tumors. Some liver transplant programs switch their immunosuppression protocol 
from tacrolimus to rapamycin in patients with high risk for HCC recurrence after transplanta-
tion. However and on retrospective studies, its effect on long term overall survival on patients 
after liver transplantation for HCC, have had conflicting results [39, 40].
The functional relationship between poly-unsaturated lipid metabolism, inflammation and 
cancer development has been discussed in multiple avenues. Cyclooxygenases (COX’s) and 
lipoxygenases (LOX’s) are enzymatic families that metabolize poly-unsaturated fatty acids. 
COX is present in two isoforms (COX-1 and COX-2) that produce prostaglandins (PG’s) and 
thromboxanes, respectively [41]. LOXs constitute a family of dioxygenases that insert O
2
 into 
poly-unsaturated fatty acids with regional specificity [41]. These metabolites are biologically 
active hydroperoxyeicosatetraenoic acids that upon reduction forms hydro-eicosatetranoic 
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acids (HETE’s), while the metabolism of linoleic acids preferentially results in hydroxyl-
octadecadienoic acids (HODE’s), metabolites known to modulate inflammation and carci-
nogenesis [41]. An excess of poly-unsaturated fatty acids could enhance a higher production 
of HETE’s and/or HODE’s with an override of pathways that enhances cancer development. 
Hepatic COX-2 overexpression induces spontaneous HCC formation in vitro and in mice 
through Akt, SKT33 and mTOR signaling cascades [42]. In the healthy liver, the inhibitor of 
the prostaglandin degrading enzyme 15-PGDH potentiates liver regeneration after partial 
hepatectomy when compared to control and sham animals [43]. Thus, prostaglandin active 
derivatives have the potential not only to modulate local inflammatory responses but to pro-
mote cell regeneration in the healthy cell and potentially reversal of cell arrest in the senes-
cent cell.
2.2. Metabolism in the liver graft
Evidence seems to indicate a peculiar aging pattern for liver grafts after transplantation. 
Biological age of the graft does not correspond to its behavior when transplanted to a differ-
ent environment of a younger recipient [44]. One of the most important intracellular protease 
systems is represented by the proteasome, the central catalytic unit of the ubiquitin-proteasome 
system (UPS). No difference in the accumulation of oxidized proteins and polyubiquitin conju-
gates with maintenance of their proteolytic activity was found in liver grafts after transplanta-
tion from younger donors to older recipient when compared to liver grafts from older donors 
placed into younger recipients. Furthermore, there was an increase of the ß5i/α4 ratio, suggest-
ing a shift towards proteasomes containing immune-subunits [44]. Thus, it appears older liver 
grafts transplanted in younger recipients switched their biological metabolism to resemble 
the recipient’s metabolic age. However, the pattern of liver cell senescence may differ. Liver 
biopsies, as judged by the senescent markers telomerase and SMP-30 from older transplanted 
livers showed histological damage in asymptomatic patients with up to 43% and 64% at 5 and 
10 years, respectively [45].
In the warm ischemic/reperfusion liver model, glycogen synthase kinase 3 (GSK-3) inhibi-
tion ameliorated liver injury upon reperfusion through an energy-dependent mitochondrial 
mechanism [46]. GSK-3 is a serine/threonine kinase regulated by inactivation through serine 
phosphorylation. GSK-3 inhibition down regulates the opening of mitochondrial permeability 
transition pore (MPTP) site, preventing leakage of mitochondrial respiratory chain proteins; a 
key step in the activation of caspase dependent apoptosis and therefore mitochondrial-depen-
dent cell termination. This effect was present in young animals but abrogated in old animals, 
and a partial response was re-established in the older group by glucose infusion with hepatic 
glycogen build up storage [46]. Authors speculated that during reperfusion glycogen degrada-
tion provides mitochondrial fuel in forms of glutamate and α-ketoglutarate maintaining enough 
energy levels that preserve mitochondrial membrane integrity or mitohormesis lowering ROS 
production, factors needed to decrease MPTP susceptibility. Former approach in the human was 
entertained, where liver graft glycogen replenishment was performed during the donor phase 
and evaluated upon reperfusion [47, 48]. Metabolic benefit with improved organ graft function 
was observed only in borderline grafts and the ones with high fat content. Nevertheless, the 
concept of metabolic replenishment with further graft function improvement may be refined by 
strategies of ex-vivo euthermic graft perfusion prior implantation [49–56].
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2.3. The chronically diseased liver
Hepatocyte senescence expression has been shown to be present in up to 80% of the cells in 
advanced liver disease [57]. The effects of insulin in the liver cell are mediated through two 
main cellular pathways: the phosphatidylinositol 3-kinase (PI3K)-Akt and the Ras-MAP kinase 
(MAPK) pathways. While both pathways are active in the regulation of cellular growth, prolif-
eration and differentiation the PI3K-Akt mediates the metabolic actions of insulin. Those actions 
include activation of mTOR1 and its S6 kinase and the inactivation of glycogen synthase kinase-3 
(GSK3) as well as its AS160 with nuclear exclusion of the Forkhead box protein (Fox01) [57]. In cul-
ture, HepG2 cell lines showed a signaling defect downstream of the Akt pathway with an impact 
upon insulin mediated Fox01 cytosol sequestration and AS160 phosphorylation; a cascade that 
translated into insulin resistance of older cells when compared to younger cells. Nevertheless, 
maintenance of the senescent state requires an active role in the transcriptional activity of Fox01 
as cell cycle inhibitor, even in the presence of growth factors. Thus, it appears gluconeogenesis 
and insulin resistance are unwanted but unavoidable effects of Fox01 gene, which is involved in 
cell cycle arrest, detoxification of oxygen species, DNA repair and gluconeogenesis [57].
FA overload can damage the respiratory chain in the mitochondrion through a dual role: as an 
un-coupler and as an inhibitor [13]. Impairment of the key respiratory state 4 → 3 can occur 
via inhibition of ATP-synthase thereby producing an increase production of ROS irrespective 
of ADP concentration. The concept of redox-optimized ROS balance (R-ORB) postulates that 
ROS efflux from the mitochondrion will attain a minimum at intermediate values of oxida-
tion, when VO
2
 reaches a maximum following ADP stimulation. Under state 3 respiration, 
GSH and thioredoxin systems are essential for minimizing ROS release from the mitochondria 
[13]. Moreover, mitochondria from cells with chronic liver disease under oxidant challenge 
displayed a two-fold increase in H
2
O
2
 emission when compared to controls along with a 50% 
decrease in GSH [13]. Since 90% of GSH in plasma is excreted by the liver, glutathione sp. could 
serve as a surrogate of cell/mitochondrial stress and their ratio in plasma may reflect over-
all liver redox balance [24]. In animal models of liver malignancy, with or without cirrhosis 
glutathione sp. (glutathione reduced-GSH, glutathione oxidized-GSSG and ophthalmate) pre-
dicted the growth of malignant cells on normal livers as early as 14 days after malignant cells 
implantation and differentiated animals with cirrhosis by tumor status (HCC+ vs. HCC−) [58, 
59]. Furthermore, glutathione sp. in plasma were part of the metabolic signature that discrimi-
nated healthy controls and subjects after liver transplantation with normal graft function from 
subjects with chronic liver disease (Figure 3). In addition, metabolic prints graded patient’s 
degree of end stage liver disease which correlated with the MELD score, and they were able to 
separate patients with cirrhosis by tumor status, i.e. HCC+ vs. HCC− [30].
Others argued mitochondrial dysfunction by FA’s respiratory chain uncoupling is incompat-
ible with thermo-regulatory principles that governs mitochondrial respiratory chain through 
energy demand: intracellular lipids will accumulate whenever FA’s supply exceeds the energy 
needs of the cell [13]. While TAG-LD in cells from a trained individual increases as the source of 
energy, in the diabetic obese subject TAG-LD are the result of accumulation with the subsequent 
potential overproduction of lipid derived toxins in the form of LCFA-CoA, diacylglycerides 
(DAG) and ceramide, metabolites responsible, at least in part for the development of insulin 
cell resistance [13]. The former theory is attractive in the heart and skeletal muscle. In contractile 
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cells, optimal excitation-contraction coupling requires an optimal energy and O
2
 supply which 
in turn affects the Ca2+ handling at the sarcoplasm reticulum (SR) release channels (ryanodine 
receptors), the SR Ca2+ pumps and the sarcolemmal Na+/Ca++ exchanger. The heart at rest beats 
in average 100,000 times per day catalyzing about 6 kg of ATP to ADP. The mitochondrion pro-
vides the ATP needed for contraction (≈66%) and the ATP needed for ion transporting (≈33%) 
essential for the cardiac electrical activity. Thus, the link among lipid supply and mitochondrial 
function, insulin sensitivity/resistance and ion pump exchange is established for optimal car-
diac function or dysfunction in the obese individual [13]. Perhaps, there is no argument lipid 
oxidation confers a metabolic advantage during starvation and exercise, but its role as the fuel 
of election during food abundance against metabolic disease deserves further studies.
In liver, cellular senescence is associated with a pro-fibrogenic environment and the relation 
between advanced liver fibrosis and shortening of the cell telomere appears to be consistent 
[11, 60]. Telomeres are repetitive DNA sequences (TTAGGG) associated with the specialized 
protein shelterin. They are located at the chromosomal end acting as a cap that stabilizes and 
protect the chromosome from erosion and miss-identification as DNA breaks. During normal 
cell division, telomeres shorten due to the “end replicating problem”: the inability of DNA 
polymerases to fully replicate the 3′ end of chromosomes [61]. Germline cells overcome this 
problem by expressing telomerase, a reverse transcriptase that maintains telomere length by 
synthetizing new DNA sequences at the end of the chromosome [60]. The telomerase complex 
includes a reverse transcriptase (TERT) and the RNA component (TERC) [61]. In other somatic 
cells, continuous cell division results in telomere shortening which in turn start signaling cell 
arrest mechanisms, i.e. senescence or apoptosis. Failure of cell arrest signaling, as in a silence 
p53 state sparks further cell proliferation with chromosomal end-to-end fusions and instability. 
In addition, exhaustion of liver regenerative paths and invested mechanisms of telomere repair 
could be overcome under continuous and chronic cell injury with subsequent acceleration of 
cell senescence and aging. Some studies had shown that telomere biology is involved in HCC 
initiation and its progression [60]. Therefore, telomere shortening is a physiological marker of 
cell aging signaling and/or cell arrest preventing further cell division; failure of cell arrest may 
end in chromosomal instability and subsequent mutations favoring tumor development [11, 
61]. In fact, the strength of the DNA damage response (DDR) in the normal cell depends ulti-
mately to the degree of p53 gene regulation: a higher p53 response is associated with apoptosis, 
a lower response is associated with cell senescence and a silence p53 response may favor tumor 
development and growth [62]. In addition, a sirtuin (SIRT7) showed an in vivo hyperacetylation 
of p53 and the SIRT7 knockout mice suffered among other maladies steatotic liver disease. 
Sirtuins were initially identified in yeast as the Silent Information Regulator (SIR). In mammals, 
SIRT protein family comprises seven distinct members involved in cellular survival, senescence 
and tumorigenesis [62]. The SIRT7 knockout mice showed a 2.5 fold increase in the liver tri-
glyceride content and an increased accumulation of hepatocyte inflammatory markers [62]. 
Findings that were associated with liver cells mitochondrial dysfunction through a deacetylate 
GABPß1 mitochondrial protein pathway and with the development of HCC through maintain-
ing a deacetylated state of H3K18 at promoters sites of many tumor suppressor genes [62].
Lipodystrophic syndromes are rare and heterogeneous diseases, genetic or acquired, where 
partial atrophy is associated with a phenotype consistent with insulin-resistant diabetes, 
dyslipidemia and NAFLD. Although the genetic cause of these syndromes are largely 
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unknown, most of the monogenic diseases have in common primary alterations in the fat 
tissue consistent with disturbances of the adipogenesis process or defects in the formation, 
maintenance and/or regulation of the lipid droplet [63]. Acquired syndromes are seen mainly 
after HIV therapy with anti-retroviral agents as zidovudine and stavudine (tNRTl’s). Agents 
known to render mitochondrial toxicity with metabolic disturbances similar to the metabolic 
syndrome seen in obesity. This metabolic adverse effects include premature aging associ-
ated with impaired prelamin-A maturation [63]. Lamin-A alterations could produce fragile 
nuclear envelopes, alter chromatin organization, increase oxidative stress and promote pre-
mature senescence at the cellular level. The metabolic disturbances observed in genetic or 
acquired lipodystrophic syndromes support the hypothesis of a primary fat compartment 
dysfunction as the source of metabolic disturbances, similar to the ones detected in obesity.
Chronic liver disease is associated with an increased translocation of intestinal bacteria con-
tributory to the liver inflammatory response and may promote the development of HCC 
[12]. Liposaccharide (LPS) produced by Gram (−) bacteria hosted in intestines from obese 
humans and rodents was associated with the transition of NAFLD to NASH and conse-
quently to its progression to cirrhosis and HCC. LPS is recognized by the Toll like recep-
tor 4 (TLR4) which is expressed upon cell activation on migrating and local macrophages 
(Kupffer cells). TLR4 is central for the secretion of TNF-ß and IL-6, cytokines present in the 
chronic inflammatory environment that precedes the detection of malignancy [12]. Further 
support to the role of LPS was found by interventions such as gut sterilization, removal 
of LPS or inactivation of TLR4; maneuvers that diminished tumor growth in chronically 
injured livers [12]. In experimental models, dietary or genetic obesity alterations on the gut 
microbiota increased levels of metabolites like deoxycholic acid (DCA) that in turn dam-
ages DNA. The enterohepatic circulation may further enhance the concentration of such 
metabolites by both encouraging the senescent-associated secretory phenotype response 
and favoring a tumor-promoting environment.
3. Cellular senescence
3.1. Hepatocytes
Historical views of liver cell replication supports the physiological properties of the hepatocytes 
to restore function as response to parenchymal loss [64]. However, massive or unending injury 
may overcome regenerative processes or may promote a dysfunctional repair process lead-
ing to progressive liver fibrosis, development of portal hypertension and eventually liver fail-
ure. Senescent status was induced in HepG2 cells by exposure to H
2
O
2
. Its consequences and 
metabolic activity were interrogated [18] and morphological changes were noted with respect 
to SA-ß-GAL and SAF’s expression, cell cycle arrest as well as the upregulation of p53, p21 and 
p16 genes. Regarding cytokine expression, IL-8 was upregulated while IL-6 was downregulated. 
Disturbances in glucose and lipid metabolism were evident with upregulation of growth hor-
mone/IGF1 (SOCS2) and glycolysis (PGM2LT). Nonetheless, the downregulation of glucoge-
nolysis and gluconeogenesis (G6PC) were more prominent. The unsaturation of fatty acids was 
hyperactive (FADS3) with parallel hypo activity of lipoprotein and hepatic lipase activity through 
the Apo-lipoprotein (APC3) system. APC3 also limits the uptake of chylomicrons by the liver 
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cell. Other fatty acid downregulated proteins included SORL1 (involved in the uptake of LDL), 
ACSM2B (a medium-chain fatty-acid-CoA ligase) and PHGDH indirectly involved in amino-acid 
synthesis [18]. In addition, senescent cells secreted a variety of bioactive molecules including pro-
inflammatory cytokines and chemokines that may influence extracellular matrix and the micro-
environment but as well modulate the immune response with the promotion of macrophage 
migration leading to further increase in the inflammatory mielue [65]. Monocyte chemotactic 
protein (MCP-1) could provide a signal for monocyte recruitment into the liver followed by acti-
vation of Kupffer cells with the upregulation of death ligands. The expression of Fas ligand, TNF-
α, and TNF-related apoptosis inducing ligand (TRAIL) further aggravates lipo-apoptosis [66]. 
In addition the FFA palmitate increases the expression of TRAIL and abrogation of the TRAIL 
receptor expression suppresses the inflammation induced by nutrient excess in mice [66].
Prior assumptions on cellular senescence determined that cell cycle arrest was a mechanism 
to protect the cell towards tumorigenesis. Nevertheless, it has been shown that the cell in cycle 
arrest can produce pro-inflammatory mediators, the senescence-associated secretory pheno-
type that promotes tumor growth [67]. During chronic liver disease, senescent machinery 
becomes “hijacked” perhaps triggering proliferation and transformation of hepatocytes, thus, 
promoting metabolic adaptation which may enhance tumor grafting and growth [68, 69]. The 
above metabolic paths could at least in part, be mediated by the over expression of the phos-
phatase and tensin homolog (PTEN) described in T-leukemia but later shown in liver tumors 
to inhibit the pentose phosphatase pathway (PPP) by binding to glucose-6-phophodiesterase 
(G6PD). With no active G6DP dimer, cells favor glycolysis with the production of lactate even 
in the presence of oxygen [70].
Aging and senescent liver cells have different genetic paths that may converge to similar meta-
bolic traits. Aging liver cells have a proliferative response after injury associated with the repres-
sion of C/EBPα, Farnesoid X Receptor (FXR), telomere reverse transcriptase (TERT), and a 
decrease in the Wnt signaling pathway [71, 72]. A physiological Wnt signaling pathway involves 
a soluble ligand that binds to the Frizzled receptor (Fzd) and the LRP5/6 co-receptor on the 
plasma membrane; this interaction activates the cytoplasmic Disheveled protein which inhib-
its the ß-catenin (Ctnnb1) destruction complex (APC, GSK3ß, and Axin) by preventing Ctnnb1 
phosphorylation and its subsequent destruction. Stable ß-catenin (intact Wnt signaling) trans-
locates to the nucleus to form a complex with Lef and Tcf transcription factors that target genes 
as c-Myc and Cyclin D1. In cell culture and a mice model of HCC, tumor growth was ablated by 
the suppression of N-Myc downregulated gene 1 (NDRG1) expression; it promoted HCC cells 
to go into cell arrest [73]. The induction of senescence on malignant cells was accomplished by 
upregulation of the tumor suppressor genes p53, p21 and p16 in addition to decreased phos-
phorylated Rb. Senescent liver cells response to injury included transcription of Nf-kB, Myb, 
Nkx2-1, Nr5a2 and Ep300 factors; proteins known to be involved in inflammation, cell differen-
tiation, lipid metabolism and chromatin remodeling. In addition, the chronic inflammatory phe-
notype of senescent cells induces telomere dysfunction and accelerates liver cell aging [74]. Thus, 
decreased physiological cell signaling that occurs with aging plus stress induced cell senescence 
may add to the lipid toxic microenvironment by promoting a vicious circle that overrules redun-
dant mechanisms that prevent uncontrolled cell division. Mechanisms that imply an apoptosis 
“switch” from a pro-apoptotic to an anti-apoptotic status. Nonetheless, it is no clear the role of 
mitochondrial Bcl-2 proteins family and their expression may determine cellular fate [75].
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Cellular events that follows are the activation/repression of factors involved in cell prolifera-
tion. In the liver cell, the known transcriptional shift includes activation of FOXO3, FOXII, 
E2F1, c-jun, C/EBPß, Myb, USF and neutralization of inhibitors of cell proliferation such as Rb 
family and C/EBP family of proteins [76]. In C/EBP-S193A mice, failure to stop liver regen-
eration after surgery correlated with the epigenetic repression of C/EBPß, p53, FXR, SIRT1, 
PGC1α and TERT. The repression was performed by a protein formed by C/EBPß-HDCAC1 
complex which also inhibit the promoters of enzymes for glucose synthesis PEPCK and G6P 
[76]. The response of cell cycle engaged hepatocytes and cell cycle arrested hepatocytes (senes-
cent cell) to injury is different and it may awake an unregulated cell growth on quiescent stem 
liver cells [76, 77]. Oval shaped liver cells may differentiate into cholangiocytes with a distinct 
metabolism and perhaps pathway towards malignancy [15, 16]. Although cholangiocytes are 
metabolically very active cells involved in the secretion and resorption of water and soluble 
bile components, they are not directly involved in the metabolism and/or regulation of biliary 
lipid species (cholesterol, bile acids and phosphatidyl-choline vesicles) [78, 79].
3.2. Hepatic stellate cells (HSC) & portal myofibroblasts (MF)
HSC are quiescent cells that express typical markers of both neural cells and adipocytes (glial 
fibrillary acid protein-GFAP, peroxisome proliferator-activated receptor gamma-PPAϪ, and 
adiponectin receptors). They are activated by cytokines, growth factors, ROS, damaged cells 
and apoptotic bodies [64]. In health, MF are located adjacent to bile duct epithelia and are the 
first responder to biliary injuries. Upon activation HSC’s acquire a MF phenotype, cells that 
upon phagocytosis of LD and/or apoptotic bodies from damaged cells get additional energy 
and became Fas-ligand and TNF-α unresponsive to apoptosis; mechanism in use for increase 
collagen synthesis and deposition [64]. Furthermore, activation of the adenosine receptor A2A increases HSC proliferation and inhibits death and senescence by down regulation of p53 and Rb 
through the cAMP-PKA/Rac1/p38 MAPK pathway [80]. Activated MF’s express CCN1/CYR61, 
an important regulator of inflammation and wound healing. Cystein-rich 61-protein (CCN1/
CYR61) is a matrix-cellular protein that induces senescence at later stages of wound healing by 
promoting tissue remodeling through fibrogenic cell apoptosis and attenuation of TGF-ß signal-
ing [81]. HSC and MF senescent fibrogenic cells no longer proliferate, thereby reducing the load 
of ECM deposition. In addition, senescent fibrogenic cells express an increase in the secretion of 
metalloproteinases (MTP’s) leading to matrix degradation. Apoptotic fragments from HSC and 
MF are cleared by natural killer cells promoting wound healing, the best characterized mecha-
nism of fibrogenesis resolution [64, 81]. NF-κB is a key regulator for HSC survival and prolifera-
tion by maintaining the expression of Mcl-2. Inhibition of NF-κB increases HSC apoptosis by 
up-regulation of the JNK pathway. Thus, the activation as well as the induction of senescence/
apoptosis of HSC/MF are normal wound healing mechanisms that promote the establishment of 
normal organ architecture and function with clear paths of initiation and resolution.
During chronic cell injury, such as in a state of high caloric intake enriched with lipids, an increase 
and progressive pool of biologically active HSC’s may become prominent [11]. An incremental 
chronic state of fibrogenesis alters hepatic architecture leading to a concomitant increase in portal 
flow resistance, portal hypertension and the development of collateral circulation. In addition, 
HSC’s produce a microenvironment with altered extracellular matrix (ECM) that provides bio-
chemical and mechanical cues to the growth and establishment of tumor cells [67]. Nevertheless, 
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since 90% of the HCC’s flourish in a highly progressive fibrotic ECM, the question raises if it 
is the changes on the microenvironment that further promotes metabolic transformation with 
an “apoptotic switch” and tumor development. Interestingly, progressive liver fibrogenic ECM 
becomes enriched with vascular growth factor (VGF) receptor promoting angiogenesis, paving 
the way for the much needed arterial high O
2
 supply for HCC expansion [67].
The different components of the ECM, cellular and non-cellular interact directly and indi-
rectly with malignant cells therefore changing the phenotype of the evolving cells that in turn 
produces feedback signals to further adapt the microenvironment to the needs of the malig-
nant cell. The link between the actin cytoskeleton and the microenvironment provides an 
input of intracellular contractile forces capable of regulating signaling pathways fundamental 
to the definition of cell phenotype, mechanism that constitute the ECM “out-side-in” code 
to the cell. In response, the anchored cells expressed adhesions molecules and secreted pro-
teins that signals HSC and other ECM regulators increasing anchoring sites in response to the 
“in-side-out” signaling [67]. Therefore, the metabolic transformation of the already stressed 
parenchymal cells help to choose a path different to senescence and necrosis but to a path of 
unregulated regeneration, thus escaping apoptosis. A path that needs an ECM differentiation 
to assure cell survival in a non-efficient energy redox status.
3.3. Sinusoidal endothelial cells (SEC)
SEC’s are specialized endothelial cells that lie flat in the liver sinusoids along and in direct 
contact with the hepatocytes. Through their membranes and specialized pores or fenes-
tra passes high concentrations of metabolites, proteins and other blood compounds, traffic 
which is regulated by the size of the fenestra. SEC’s play a critical role in immune-activa-
tion, rolling of T cells, macrophages and PMN migration. Liver sinusoidal endothelial cells 
may be affected with age and obesity. SEC from old individuals have impaired and reduced 
expression of VEGF likely due to impaired nuclear transport of P-STST3 and P-CREB tran-
scription factors [82, 83]. In a rodent model of sepsis, endothelial nitrogen oxide synthase 
(eNOS) deficient mice and aging mice had the same mortality and mitochondrial dysfunc-
tion upon the isolation of SEC mitochondrion [84]. In obesity and during early fibrogenesis, 
SEC lose their fenestra, decreasing the exchange of metabolites and increase the secretion of 
several basement membrane components (type IV collagen, perlecan, entactin and laminin) 
[64]. Authors concluded that an endothelial base-line dysfunction in the aging animal is 
manifested by a weakened antioxidant response and inappropriate energy production from 
mitochondrial dysfunction due to a tipped-balance of the SEC oxi-redox systems when 
exposed to additional stress. This is seen in the obese towards a state of energy depletion 
and cellular death, apoptosis or activation of a pro-coagulant/pro-fibrogenic phase. The 
changes of SEC’s with aging may limit O
2
 delivery and availability to liver cells with its 
potential effects on mitochondrial function, a pro-fibrogenesis state and the promotion of 
insulin resistance status. Changes exaggerated in obesity, implying obesity may promote 
accelerated SEC aging processes. Interestingly, endothelial cellular senescence was inhib-
ited in vitro and in the rodent by the activation of the liver x receptor (LXR), a nuclear recep-
tor involved in the control of hepatic lipid and cholesterol metabolism [85]. Furthermore, 
LXR has been shown to play an important role in glucose metabolism, cytokine production 
and anti-inflammatory response.
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Three types of SEC’s co-exist in the normal liver sinusoid: mature SEC, SEC progenitors and bone 
marrow-derived SEC progenitors [86]. Mature SEC are gatekeepers of fibrogenesis by maintaining 
HSC in their inactivated state. SEC’s regulate sinusoidal blood flow through their action on HSC 
and thus keep a low portal pressure [86]. In addition, mature SEC’s have the largest endocytic 
capacity in the body fulfilling their dual cell clearance capacity (from the arterial/systemic and 
portal/gut systems). The liver endocytic function has been implicated in a liver-renal axis where 
the lack of SEC-stabilin-2 receptors inhibit the clearance of toxic molecules that manifest with mild 
liver fibrosis without liver dysfunction but with renal glomerular fibrosis. Not only do SEC’s have 
many glycoproteins that serve as receptors for bacterial epitopes but as receptors for immune-
modulation and pro-coagulant activity. The above mentioned SEC functions are at least partially 
lost at the time of sinusoid capillarization [86]. SEC capillarization is characterized by the disap-
pearance of the fenestrae, development of a basement membrane and the appearance of character-
istic markers. This phenomenon happens in chronic liver injury and it precedes activation of HSC 
and sequestration of macrophages. The angiogenesis process that follows is mediated by VEGF, an 
angiocrine response that drives neo-vessel formation in direct proportion to the degree of the sinu-
soidal pressure gradient. Furthermore, SEC pseudo-capillarization refers to changes that occur 
in endothelial cells associated with aging and senescence. It is manifested by a decrease of up to 
50% of their fenestrae, development of a patchy basement membrane and partial SEC dysfunction 
[86]. Chronic exposure of high fat diet may accelerate aging/senescence of SEC, endothelial dys-
function with recruitment of systemic immune cells and activation of Kupffer cells inducing HSC 
into a fibrogenic state followed by an angiocrine response that decreases hepatic blood flow, O
2
 
delivery, and clearance of toxic molecules. As metabolic stress of neighbor hepatic cells already in 
mitochondrial distress due to fat accumulation progresses, a constant and growing inflammatory 
mielue enhances tumor development, immune-recognition failure and malignant cell expansion.
Interestingly, aging endothelial cells from the fat compartment of mice was associated with 
adipose dysfunction manifested by ectopic (liver) fat deposition and adipose tissue fibrosis, 
increased adipose mitochondrial oxygen flux, altered lipid utilization, increased tissue oxida-
tive stress and lower gene expression in visceral fat [87]. Nevertheless, and most important, 
these findings were associated with reduce fat tissue vascularity, reduced angiogenic capac-
ity and endothelial dependent dilation with reduced nitric oxide (NO) bioavailability [87]. 
Limited oxygen mitochondrial availability contributes to the pro-oxidative older adipose tis-
sue phenotype that can further impair both insulin action and vascular function, a key element 
in local and systemic insulin-resistant related metabolic syndromes. Changes that are exagger-
ated in obesity, implying obesity may promote accelerated aging processes in many organs.
3.4. Resident liver immunocells
The anatomical location of the liver and its dual blood supply ensures an optimal exposure of 
antigens to the hepatic resident immune cells not only from nutrients and GI microbiota but 
from systemic compartments, such as the adipose compartment. Kupffer cells in concert with 
NK, CD4+ T-cells, and local antigen presenting cells modulates the liver immune status. Kupffer 
cells constitutes 80% of the tissue fixed macrophages and 20% of the non-parenchymal cell 
population of a normal liver [9]. Their characteristic macrophage activity is polarized mainly in 
portal tracts where the antigen dynamics is higher from food and bacteria. Innate macrophages 
have the potential to initiate an inflammatory response of different proportions by upregulating 
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adhesion molecules such as ICAM-1, and cytokines as TNF-α, IL-1, IL-6, MIP1α, TGF-ß and 
RANTES. Activation that can only lead to antigen presenting, cell to cell communication and 
amplification and enrichment of the microenvironment with ROS promoting subsequent 
parenchymal cell apoptosis/necrosis. Natural Killer (NK) and CD8+ T cells developed a specific 
signature in livers with NASH from mice under HFD [88]. The depletion of CD8+ T cells pro-
tected murine from NASH progression but not from weight gain. In addition, NK T-cells in the 
liver expresses markers that recognize lipid antigen CD1d [9]. Liver NK cells undergo Thymus 
clonal double deletion but are positive for CD3 and CD56 and they were thought to be CD1d 
independent. Nevertheless, hepatic antigen-presenting cells may introduce microbial glyco-
lipid antigens to NK cells, stimulating secretion of Th1 or Th2 cytokines which subsequently 
initiates an adaptive response. Hepatic NK cells have as well the ability to secrete osteopontin 
and sonic hedgehog, molecules known to promote the transition from NAFLD to NASH [9].
The most accepted hypothesis, continuous cell parenchymal damage and necrosis adds to a 
chronic inflammatory environment a dysregulation of the cell cycle regenerative process ren-
dering tandem mutations and thus malignant cells was challenged [89]. On the NEMO knock-
out mouse, authors were able to develop HCC through a death receptor-independent FADD 
signaling pathway. Nevertheless, it wasn’t until recently that the link between a metabolic 
hostile microenvironment, immune-recognition failure and HCC presence was established 
[90]. The enrichment of linoleic acid in the cirrhotic microenvironment of NASH patients 
promotes disruption of mitochondrial function in a greater proportion than other fatty acids 
as palmitic acid. Since CD4(+) T lymphocytes have a larger mitochondrial load than CD8(+) T 
lymphocytes, they not only generate more mitochondrial derived ROS but CD4(+) cells may 
undergo larger selective loss of mitochondrial function and viability. Therefore, disruption 
of mitochondrial function by linoleic acid mediates selective loss of intrahepatic CD4(+) T 
lymphocytes, status associated with HCC presence. Local metabolic changes could alter the 
immune response to a one that favors malignant cell expansion.
In the obesogenic environment, aberrant activation of immune cells has emerged as key fea-
tures of the metabolic syndrome. The interaction between the adipose compartment and the 
liver tissue has been hypothesized as a critical interface for nutrient sensing and metabolic con-
trol [9]. In the rodent model, neutrophils infiltrate the adipose compartment as early as 3 days 
after starting a high fat diet, however its role as well as the role of basophils and eosinophil cells 
has not yet been clarified. Mast cells, which has been observed in increasing number have been 
implicated in the secretion of IL-6 and IFN-Ϫ [9]. Moreover, leptin, a hormone secreted specifi-
cally by adipocytes has been found to be increased during high fat diets and upregulated the 
expression of leptin receptors on NK T-cells. This regulation is time sensitive, and chronic leptin 
stimulation change NK cells from an inflammatory like response to a damped one, favoring at 
long term, in the liver and perhaps in other organs a susceptibility to low recognition of no self-
cells, impaired anti-tumor surveillance and a flourishing nest of cancer. The former hypothesis 
finds support in the obese mice, where it was observed a switch from the normal Th1 immuno-
response to the Th17 immunorepertoire, phenotype that deteriorates autoimmunity [9].
3.5. Extracellular matrix (ECM)
The extracellular matrix (ECM) is formed by a non-cellular component in tissues and organs 
composed primarily of water, proteins and proteoglycans. Components created an intricate 
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scaffold where organ cells get structural support with a dynamic and continuous traffic of water, 
ions, metabolites, proteins and cells on passant to maintain organ physiology. As such, ECM 
interactions with organ cell components regulate cell differentiation, adhesion, proliferation, 
migration and survival [64]. The collagen family is the major fibrillar proteins of the ECM and 
the body (approx. 30% of the total protein contain) [64]. There are three main classes of collagen, 
fibril-forming which include types I, II, III, XI, XXIV and XXVII the most common varieties and 
their role is mainly mechanical by conferring tensile strength to both tissue and organs. Fibril-
associated collagens with interrupted triple helix (FACIT’s) includes type IX, XII, XIV, XIX, XX, 
XXI and XXII; this subclass of proteins do not form fibrils themselves but bind to the surface of 
pre-existing collagen favoring fibril enlargement. Finally, type III collagen serves as anchoring 
collagen between the epithelial cells and the lamina reticularis constituting the basement mem-
brane where type IV collagen is most abundant. Non-collagenous proteins include fibronec-
tin, tenascin, laminins, fibrillins and matrix-cellular proteins. While the former peptides play a 
major role in cell differentiation, cell growth, adhesion and migration, matrix-cellular proteins, 
i.e. thrombospondin-1 and 2, osteonectin, osteopontin and cyr-61/connective tissue growth fac-
tor (CTGF) serve mainly as a vehicle for cell signaling. Proteoglycans are carbohydrate enriched 
proteins which retain large quantities of water regulating the smooth trafficking of molecules to 
and from the cell with numerous signaling active sites for growth factors.
The ECM continuous remodeling is a complex process that integrates proteins and cellular 
components from local and distal environments [64]. The degradation of ECM proteins are 
closely controlled by matrix metalloproteinases (MMP’s), a superfamily of zinc-dependent 
endopeptidases highly regulated by specific inhibitors such as the tissue inhibitor of metal-
loproteinases (TIMP’s). In the liver, cellular component involved in collagen synthesis and 
deposition included HSC, MF and vascular smooth muscle cells [64]. In chronic liver injury, 
an override mechanism of collagen deposition regulation promotes massive ECM expansion. 
The characteristic features of abnormal liver fibrogenesis as a consequence of continuous liver 
injury and activation of collagen secreting cells include damage to the epithelial/endothe-
lial barrier, recruitment of inflammatory cells, secretion of cytokines and other inflammatory 
mediators, further generation of ROS, progressive deposition of collagen with expansion of 
ECM and worsening organ fibrosis and subsequent metabolic changes of portal hypertension.
4. Mitochondrial senescence
The mitochondria, a double membrane cell organelle varies in number and its presence is linearly 
associated with the metabolic activity of the organ and its required energy requirements in form 
of ATP. Within the mitochondrial matrix a series of biochemical reactions occur. Acetyl-choline 
primer is reduced through the tricarboxylic acid cycle converting glycolysis-derived pyruvate 
into NADH and succinate. The former compounds couple another set of reactions at the inner 
membrane border where the electron transport chain (ETC) is present to boil an oxidative phos-
phorylation process. The ETC is composed of five enzymatic complexes (I to V; NADH-CoQ, 
succinate-CoQ, CoQ-cytochrome reductases, cytochrome c oxidase and ATP synthase, respec-
tively) where NADH is the substrate of ETC-C1 and succinate the substrate of ETC-CII [10]. 
After oxidation, electrons are transferred from Complex I to CII to CIII and finally to Complex 
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IV where oxygen is reduced to form H
2
O. The electron transport process is coupled to a proton 
pumping process creating a proton gradient between the mitochondrial membranes, gradient 
that is dissipated by Complex V (ATP synthase) through ATP synthesis. A control mechanism 
is created by the “proton leak”, mechanism that generates heat instead of ATP [10]. Much of the 
leak is a catalytic reaction generated by the uncoupling proteins (UCP’s) which play an impor-
tant role in reducing proton gradient, heat and ROS [10]. Mitochondrial aging and senescence 
are linked to reduced ATP production and increase ROS production, i.e. superoxide (O2−), hydro-
gen peroxide (H
2
O
2
) and hydroxyl radical (OH−) which are mostly produced because electron 
leakage at the level of CI and CIII [17]. Mitochondria function benefit from the role of estrogen in 
plasma through its binding to the nuclear estrogen receptor that enhances a signaling to prevent 
oxidant stress and also inhibits the renin-angiotensin-aldosterone system [10]. Thus, sex differ-
ences in mitochondrial function may explain the disparity in overall survival between men and 
women, differences that may be taken into account during animal models studies.
The reasons why the mitochondrion conserves a cell independent genome are not clear, but 
it is intuitive to imply self-energy regulatory processes are united through a fine tune mecha-
nism between energy expenditure (ATP use) and energy production (ATP synthesis) at every 
organelle level. It may provide an overall advantage for survival of the cell, the organ and 
entire biological living system. The gradual ROS response theory of aging argues a protective 
role of ROS in early life, when cell oxidative damage and ROS production are low; however, 
later in life ROS reaches a level where its beneficial effects (as the one observed in dietary 
restriction and/or exercise) are overcome by its detrimental effects elicited by a higher cell 
oxidative stress (as the one observed in high fat diet and sedentary habits) [17]. The effects that 
are amplified include loss of genomic controls (p53), microRNA dysregulation, loss of function 
of telomerase reverse transcriptase (TERT) and a lower immune-surveillance status. Although 
the role of p53 in the mitochondrion is not completely clear, p53 binds to the Peroxisome 
proliferator-activated receptor Gamma-Coactivator 1 alpha and Beta (PGC-1α and ß) foment-
ing their inhibition of expression and therefore downregulated oxidative function. In addition, 
p53 target p16 and p21, factors that triggers G1-phase cycle arrest by inhibiting cell cycle regu-
latory kinases Cdk4 and Cdk2 [17]. The third known effect of p53 at the mitochondrion level is 
to promote cell apoptosis by increasing mitochondrial membrane permeability with leakage of 
cytochrome proteins, a direct activator of the caspase cascade. The function of TERT is highly 
affected by levels of ROS production and its protective patterns are only observed with low 
ROS levels. The role of microRNA in the mitochondrial environment remains to be elucidated.
The Mitochondrial Free Radicals Theory of Aging (MFRTA) has been the most popular theory 
to explain the cell aging process where increasing production of mitochondrial ROS with lower 
ATP production are the main factors responsible for cell aging and corresponding mitochon-
drial ultrastructure changes [17, 91]. As mentioned, leakage of electrons at the level of CI and 
CIII transfer are larger with age and the higher potential for DNA damage. 8-oxo-7.8-dihydro-
2′deoxyguanosine (8-oxodG) is one of the most abundant DNA mutations caused by oxidative 
conversion to guanosine. Furthermore, its accumulation follows an inverse and exponential 
curve against life expectancy in several mammals [17]. Recently, it was described that humans 
with longer longevity have a higher content of mitochondrial DNA (mtDNA) per cell in different 
organs, and support the notion of ethnic background on mtDNA influence and life span. The 
frequency of mtDNA mutations occurs at different rate depending on the organ. Skeletal and 
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cardiac muscles, liver and kidney are more affected by somatic mtDNA mutations compared to 
other organs such as the skin and lung [17]. Furthermore, the clonal expansion of mtDNA muta-
tions occurs via a phenomenon called genetic drift, a random propagation and expansion of DNA 
mutations occurring at each DNA replication. The drift of mutations may be more important in 
metabolically more active organs that require more energy expenditure and therefore more ATP 
synthesis. The expansion of mtDNA mutations may be enhanced not only by its duplication and 
drift but also by a lower state of DNA damage repair mechanisms [17]. The Base Excision Repair 
(BER) process is impaired in senescence and aging due to a loss of function to BER associated 
proteins CSA and CSB. Thus, the increase production of ROS creates a vicious loop of mtDNA 
mutations than in turn favor an increase production of ROS perpetuating and enhanced organelle 
dysfunction by defective reparative mechanisms. A naturally occurring thymidine to cytidine 
mutation in the mitochondrial stressors tRNAILE gene is associated with phenotypes of hyperten-
sion, hypercholesterolemia and hypomagnesemia [10]. Furthermore, the DNA A3243G mutation 
causes impaired insulin secretion and polymorphisms in the promoter of the UCP2 protein, alter-
ations associated with increased incidence of obesity, reduced insulin secretion and DMII [10].
Mitochondrial function may be impaired in chronic high fat diet challenge as a result of a 
decrease in ß-lipid oxidation. Indirect evidence showed an accumulation of diacylglycerol 
and fatty-Acyl-CoA which in turn activates stress-related serine/threonine kinase activity and 
inhibit glucose transport [10]. Oxidative stress contributes further to impaired insulin signaling 
increasing UCP2 activity which in turn enhances “proton leak” with uncoupling of the glucose 
metabolism pathway and decreased ATP production. A progressive higher lipid peroxidation 
may favor further oxidative stress with DNA damage and low DNA repair by affecting mem-
bers of the Bcl-2 family, triggering an influx of Ca2+ with subsequent opening of the mitochon-
drial permeability transition pore, cytochrome-c leakage to the cytosol and activation of the 
caspace-3 complex. Cell self-digestion and nuclear DNA fragmentation overcomes with the 
typical cell fragments morphology [10]. Alternatively, DNA damage and telomerase shortening 
results in mutations that may affect mitochondrial function to a level of organelle survival but 
inefficient ATP production assuring the “apoptosis switch” and diverting biochemical reactions 
to a cytosolic site for ATP production. The later assumption may find some support in the obser-
vations that tumor development and early growth is favored in low O
2
 delivery zones and that 
tumor development is associate with increase lactate production, the Warburg effect [30, 69].
5. Future directions
Prevention of metabolic syndrome and its health consequences is primordial. A healthy diet 
that is balanced not only in calories but also in its components, specially fats and carbohydrates 
would avoid fat storage spillage from a saturated fat body compartment. In addition, a sub-
stantial use of lean mass through directed exercise will decrease further cell, organ and body 
aging. In the brain, the melacortin forms a network of neural food sensing connecting signals of 
metabolic rate with neurological sites that regulates food intake behaviors and energy expendi-
ture homeostasis. Central administration of α-MSH reduces food intake and may also increase 
energy expenditure resulting in weight loss [92]. Metabolic disturbances in the liver renders liver 
cell changes that progress from NAFLD to NASH to cirrhosis and malignancy. A non-invasive 
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plasma based monitoring of such changes on disease progression and treatment response as 
well as for tumor screening may be possible by metabolomic liver prints in the near future [30].
There have been a myriad or reports on compounds that not only prevent but reverse cell aging 
and some even malignant development in the animal model [25, 93–102]. Curcumin, the major 
bioactive compound of turmeric spice, through its antioxidant and anti-inflammatory properties 
has been claimed to retard tumorigenesis and diabetes and to modulate lipid metabolism [103]. 
Furthermore, curcumin prevents the development of atherosclerosis and NASH, perhaps by the 
upregulation of a fatty acid binding protein present in adipocytes (aP2) but also found in macro-
phages (FABP-4). This protein is a cytosolic protein present in adipocytes and macrophages which 
modulates the trafficking of lipids/cholesterol processes and activation of inflammatory mecha-
nisms through CD36 upregulation and reduced expression of NF-kß thus, decreasing cytokine 
secretion [103]. Prior studies showed that high fat diet and obesity promoted liver tumorigenesis 
by inducing chronic inflammation through the IL6/STAT3 pathway and, STAT3 activated tumors 
has been showed to be more aggressive in humans. Lycopene attenuated HCC occurrences in 
the animal model through downregulation of the STAT3 signaling [95]. The aqueous extract of 
Ligustrum lucidum fruit induced apoptosis through the activation of the caspase cascade and cel-
lular senescence by upregulation of p21 and downregulation of RB phosphorylation [102].
Other molecules with promising cell aging and tumor repression properties included the 
COX-2 and a Na/K/ATP signaling mechanisms. Inhibition of 15-hydroxyprostaglandin dehy-
drogenase (15-PGDH), a prostaglandin-degrading enzyme, potentiates tissue regeneration 
in multiple organs in mice [43]. During a chemical screen, a low molecular compound was 
identified capable of selectively inhibiting 15-PGDH with the subsequent increase of PGE2 
levels in bone marrow and other organs, accelerating hematopoietic recovery in mice receiving 
bone marrow transplant and tissue regeneration in the colon and liver. It also promoted tissue 
regeneration in mouse models of colon and liver injury. Selective COX-2 products may have 
rescued telomere dysfunction, cell senescence and tissue regenerative potential [74]. However, 
its mechanism and signal transduction remains to be determined. pNaKtide is a synthetic pep-
tide that conserves the active sequence for the ligand-binding capacity to the ß-subunit of the 
transmembrane Na/K-ATPase. Although the Na/K-ATPase mainly exercise its function as an 
ion exchanger pump vital for cell survival, recently it was shown to elicit nuclear signaling 
that regulates mitochondrial function and cell energy production through a Src/ERK pathway 
[104–112]. Furthermore, pNaKtide prevents the development of atherosclerosis and fatty liver 
disease in the HFD mice model with significant amelioration of ROS. In addition, it down-
regulates collagen synthesis and inhibit growth of human cancer cells in vitro. Translation of 
promising compounds to the treatment of patients with NAFLD/NASH is expected in the near 
future to further prevent the consequences of advanced liver fibrosis and HCC development.
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